Fibrocell Science Inc (FCSC) 2011年年度报告「NASDAQ」.pdf

1、Table of Contents UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM 10-K xAnnual Report Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934For the fiscal year ended December 31,2011OR Transition Report Pursuant to Section 13 or 15(d)of the Securities Exchange

2、 Act of 1934 Fibrocell Science,Inc.(Exact name of registrant as specified in its Charter.)Delaware 001-31564 87-0458888(State or other jurisdictionof incorporation)(CommissionFile Number)(I.R.S.EmployerIdentification No.)405 Eagleview BoulevardExton,Pennsylvania 19341(Address of principal executive

3、offices,including zip code)(484)713-6000(Issuers telephone number,including area code)Securities registered pursuant to Section 12(g)of the Act:Title of Each ClassCommon Stock,$.001 par value Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Secur

4、ities Act.Yes No xIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Act.Yes No xIndicate by check mark whether the registrant:(1)filed all reports required to be filed by Section 13 or 15(d)of the Exchange Act during the preceding1

5、2 months(or for any shorter period that the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past90 days.Yes x No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site,if any,every Inter

6、active Data Filerequired to be submitted and posted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorterperiod that the registrant was required to submit and post such files).Yes x No Indicate by check mark if there is no disclosure of del